October 22, 2024 at 11:17 am

Quoin Achieves New Milestone with Further Expansion of Global Netherton Syndrome Clinical Trials

Expansion underscores Company commitment to delivering a globally approved treatment for Netherton Syndrome    Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, will extend its ongoing Netherton Syndrome (NS) clinical studies to two additional international sites in London: Great Ormond Street Hospital and St. Thomas’ Hospital…. [Read More]
October 21, 2024 at 12:55 pm

Trevi Therapeutics Completes Enrollment for Phase 2a Chronic Cough Trial; Topline Results Expected Q1 2025

Trevi Therapeutics (Nasdaq: TRVI) has completed enrollment for its Phase 2a trial evaluating Haduvio™ (oral nalbuphine ER) for the treatment of refractory chronic cough (RCC). The trial, conducted across multiple sites in the U.K. and Canada, enrolled approximately 60 patients to assess the safety, efficacy, and dosing of Haduvio. Topline results are anticipated in the… [Read More]
October 21, 2024 at 12:01 pm

PharmAla’s LaNeo MDMA to Power Mt. Sinai Clinical Trial; Shares Surge 27%

PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: MDXXF) has announced it will supply its GMP-grade LaNeo™ MDMA to a clinical trial at Mt. Sinai Health System. This collaboration underscores PharmAla’s dedication to delivering high-quality MDMA for cutting-edge clinical research. CEO Nicholas Kadysh expressed excitement about working with Mt. Sinai’s renowned team of researchers, particularly for… [Read More]
October 21, 2024 at 11:26 am

A Better Way to Get Baked: Green Thumb Industries incredibles Brand Expands Partnership with World-Famous Magnolia Bakery

Green Thumb Industries (GTBIF) award winning cannabis edibles brand incredibles will be expanding its partnership with New York City’s Magnolia Bakery. This week incredibles’ chocolate will be combining with Magnolia’s iconic flavors to introduce two new THC infused bars, Swirled Famous Banana Pudding Bar and the Red Velvet Piece Ahhh Cake 1:1 Bar. Medical patients… [Read More]
October 21, 2024 at 10:49 am

S&P 500 Earnings: How It’s Going and What Will Be Coming Up This Week

Over the next two weeks we will be in the peak of Q3 earnings season. So far, earnings sentiment has been fairly upbeat with approximately 14% of the S&P 500 having reported. According to FactSet, nearly 80% of reporters have beat consensus EPS expectations and earnings are surprising to the upside by over 6% in… [Read More]